Pfizer/BioNTech and Moderna's bivalent vaccines now be used as people's first shots. Read more at straitstimes.com.
THE HAGUE - The EU’s drug watchdog on Tuesday said two Covid-19 vaccines targeting new types of the Omicron variant could now be used for people’s first vaccinations, and not just for boosters.
The Amsterdam-based regulator said its emergency task force had now decided the two vaccines “may be used for primary vaccination. These vaccines are currently only authorised as boosters.”The decision came after it reviewed laboratory studies on the immune response from the so-called “bivalent” vaccines, which target the new Omicron types as well as the original Covid-19 virus that emerged in China in late 2019.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Pfizer, BioNTech counter-sue Moderna over Covid-19 vaccine patentsModerna first sued Pfizer in August, accusing the company of violating its rights in three patents. Read more at straitstimes.com.
続きを読む »
Airlines to return to profit in 2023 for the first time since Covid-19 hitThe world’s carriers are seen chalking up $6.5 billion in net profits in 2023, IATA forecasts. Read more at straitstimes.com.
続きを読む »
EU regulator backs bivalent COVID-19 shots for primary vaccinationThe European Medicines Agency said on Tuesday (Dec 6) its emergency task force has concluded that messenger RNA bivalent COVID-19 vaccines, targeting the original strain and the Omicron BA.4-5 subvariants, may be used in previously unvaccinated children and adults. The recommendation is based on data which
続きを読む »
Bivalent Pfizer vaccine available to all aged 12 and aboveFrom Dec 12, those aged 12 and above can get the bivalent Pfizer-BioNTech/Comirnaty Covid-19 vaccine to enhance their protection against the Omicron variants of the coronavirus. Those who are eligible will progressively receive a text message with a personalised booking...
続きを読む »
Bivalent Pfizer-BioNTech Covid-19 vaccine jabs available to those aged 12 and above from Dec 12SINGAPORE — From next Monday (Dec 12), Singapore residents the Ministry of Health (MOH) will roll out the bivalent Pfizer-BioNTech/Comirnaty Covid-19 vaccine for persons aged 12 and above.
続きを読む »
Bivalent Pfizer-BioNTech COVID-19 vaccine to be available to people aged 12 and above from Dec 12Singapore's Health Ministry also announced that children aged six months to four years will soon be able to receive the Pfizer-BioNTech/Comirnaty COVID-19 vaccine.
続きを読む »